Skip to main content
Premium Trial:

Request an Annual Quote

Sherlock Biosciences: Paul Meister

Paul Meister will join the board of directors of Sherlock Biosciences in conjunction with the company's recent $80 million Series B financing round. He is a partner at Novalis LifeSciences, the lead investor in the round.